메뉴 건너뛰기




Volumn 43, Issue 1, 2005, Pages 6-8

Probiotics for atopic diseases
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

EID: 17844394987     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2005.4316     Document Type: Article
Times cited : (6)

References (25)
  • 2
    • 8744242021 scopus 로고    scopus 로고
    • Probiotics for gastrointestinal disorders
    • Probiotics for gastrointestinal disorders. DTB 2004; 42: 85-8.
    • (2004) DTB , vol.42 , pp. 85-88
  • 3
    • 0024417450 scopus 로고
    • Hay fever, hygiene, and household size
    • Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-60.
    • (1989) BMJ , vol.299 , pp. 1259-1260
    • Strachan, D.P.1
  • 4
    • 0035495857 scopus 로고    scopus 로고
    • The germless theory of allergic disease: Revisiting the hygiene hypothesis
    • Wills-Karp M et al. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nature Rev Immunol 2001; 1: 69-75.
    • (2001) Nature Rev. Immunol. , vol.1 , pp. 69-75
    • Wills-Karp, M.1
  • 5
    • 0037134046 scopus 로고    scopus 로고
    • Allergy, parasites, and the hygiene hypothesis
    • Yazdanbakhsh M et al. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 490-4.
    • (2002) Science , vol.296 , pp. 490-494
    • Yazdanbakhsh, M.1
  • 6
    • 5444233803 scopus 로고    scopus 로고
    • Dietary modification of atopic disease: Use of probiotics in the prevention of atopic dermatitis
    • Isolauri E. Dietary modification of atopic disease: use of probiotics in the prevention of atopic dermatitis. Curr Allergy Asthma Rep 2004; 4: 270-5.
    • (2004) Curr. Allergy Asthma Rep. , vol.4 , pp. 270-275
    • Isolauri, E.1
  • 7
    • 0036795932 scopus 로고    scopus 로고
    • Pro and anti: The biotics of allergic disease
    • Crane J. Pro and anti: the biotics of allergic disease. Thorax 2002; 57 (suppl II): 1140-6.
    • (2002) Thorax , vol.57 , Issue.SUPPL. II , pp. 1140-1146
    • Crane, J.1
  • 8
    • 0036298165 scopus 로고    scopus 로고
    • Aberrant composition of gut microbiota of allergic infants: A target of bifidobacterial therapy at weaning?
    • Kirjavainen PV et al. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 2002; 51: 51-5.
    • (2002) Gut , vol.51 , pp. 51-55
    • Kirjavainen, P.V.1
  • 9
    • 7444248463 scopus 로고    scopus 로고
    • Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis
    • Rosenfeldt V et al. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004; 145: 612-6.
    • (2004) J. Pediatr. , vol.145 , pp. 612-616
    • Rosenfeldt, V.1
  • 10
    • 0031041742 scopus 로고    scopus 로고
    • Probiotics: A novel approach in the management of food allergy
    • Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-85.
    • (1997) J. Allergy Clin. Immunol. , vol.99 , pp. 179-185
    • Majamaa, H.1    Isolauri, E.2
  • 11
    • 0035820307 scopus 로고    scopus 로고
    • Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial
    • Kalliomäki M et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076-9.
    • (2001) Lancet , vol.357 , pp. 1076-1079
    • Kalliomäki, M.1
  • 12
    • 0033677619 scopus 로고    scopus 로고
    • Probiotics in the management of atopic eczema
    • Isolauri E et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604-10.
    • (2000) Clin. Exp. Allergy , vol.30 , pp. 1604-1610
    • Isolauri, E.1
  • 13
    • 0037530080 scopus 로고    scopus 로고
    • Probiotic bacteria in the management of atopic disease: Underscoring the importance of viability
    • Kirjavainen PV et al. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003; 36: 223-7.
    • (2003) J. Pediatr. Gastroenterol. Nutr. , vol.36 , pp. 223-227
    • Kirjavainen, P.V.1
  • 14
    • 0037327049 scopus 로고    scopus 로고
    • Effect of probiotic Lactobacillus strains in children with atopic dermatitis
    • Rosenfeldt V et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-95.
    • (2003) J. Allergy Clin. Immunol. , vol.111 , pp. 389-395
    • Rosenfeldt, V.1
  • 15
    • 0036196197 scopus 로고    scopus 로고
    • No effect of oral treatment with an intestinal bacterial strain,, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: A placebo-controlled double-blind study
    • Helin T et al. No effect of oral treatment with an intestinal bacterial strain,, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002; 57: 243-6.
    • (2002) Allergy , vol.57 , pp. 243-246
    • Helin, T.1
  • 16
    • 1842683055 scopus 로고    scopus 로고
    • Treatment of perennial allergic rhinitis with lactic acid bacteria
    • Wang MF et al. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004; 15: 152-8.
    • (2004) Pediatr. Allergy Immunol. , vol.15 , pp. 152-158
    • Wang, M.F.1
  • 17
    • 0036157880 scopus 로고    scopus 로고
    • Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant
    • Rautava S et al. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109: 119-21.
    • (2002) J. Allergy Clin. Immunol. , vol.109 , pp. 119-121
    • Rautava, S.1
  • 18
    • 0038730917 scopus 로고    scopus 로고
    • Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial
    • Kalliomäki M et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869-71.
    • (2003) Lancet , vol.361 , pp. 1869-1871
    • Kalliomäki, M.1
  • 19
    • 0027510240 scopus 로고
    • Severity scoring of atopic dermatitis: The SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis
    • Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
    • (1993) Dermatology , vol.186 , pp. 23-31
  • 20
    • 4844230911 scopus 로고    scopus 로고
    • Tolerance of probiotics and prebiotics
    • Marteau P, Seksik R Tolerance of probiotics and prebiotics. J Clin Gastroenterol 2004; 38 (suppl 2): S67-9.
    • (2004) J. Clin. Gastroenterol. , vol.38 , Issue.SUPPL. 2
    • Marteau, P.1    Seksik, R.2
  • 21
    • 0033767920 scopus 로고    scopus 로고
    • Saccharomyces cervisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii
    • Cesaro S et al. Saccharomyces cervisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 2000; 8: 504-5.
    • (2000) Support Care Cancer , vol.8 , pp. 504-505
    • Cesaro, S.1
  • 22
    • 0034890663 scopus 로고    scopus 로고
    • Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis
    • Farina C et al. Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis. J Clin Gastroenterol 2001; 33: 251-2.
    • (2001) J. Clin. Gastroenterol. , vol.33 , pp. 251-252
    • Farina, C.1
  • 23
    • 0032930367 scopus 로고    scopus 로고
    • Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii
    • Niault M et al. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clin Infect Dis 1999; 28: 930.
    • (1999) Clin. Infect. Dis. , vol.28 , pp. 930
    • Niault, M.1
  • 24
    • 0029664713 scopus 로고    scopus 로고
    • "Probiotic" remedies are not what they seem
    • Hamilton-Miller JM et al. "Probiotic" remedies are not what they seem. BMJ 1996; 312: 55-6.
    • (1996) BMJ , vol.312 , pp. 55-56
    • Hamilton-Miller, J.M.1
  • 25
    • 0037196211 scopus 로고    scopus 로고
    • Deficiencies in microbiological quality and labelling of probiotic supplements
    • Hamilton-Miller JM, Shah S. Deficiencies in microbiological quality and labelling of probiotic supplements. Int J Food Microbiol 2002; 72: 175-6.
    • (2002) Int. J. Food Microbiol. , vol.72 , pp. 175-176
    • Hamilton-Miller, J.M.1    Shah, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.